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Abstract
Background: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis is an immune-mediated syndrome caused
by the production of anti-NMDAR receptor antibodies. The syndrome characterised by psychosis, seizures, sleep
disorders, hallucinations and short-term memory loss. Ovarian teratoma is the confirmed tumour associated with
anti-NMDAR antibodies. The patients with anti-NMDAR encephalitis complicated by ovarian teratoma require
surgical treatment under general anesthesia. NMDARs are important targets of many anesthetic drugs. The
perioperative management and complications of anti-NMDAR encephalitis, including hypoventilation, paroxysmal
sympathetic hyperactivity (PSH) and epilepsy, are challenging for ansthesiologists.
Case presentation: This report described two female patients who presented for resection of the ovarian teratoma,
they had confirmed anti-NMDAR encephalitis accompanied by ovarian teratoma. Two patients received gamma
globulin treatments and the resection of the ovarian teratoma under total intravenous anesthesia. They were recovered
and discharged on the 20th and 46th postoperative day respectively.
Conclusions: There is insufficient evidence about the perioperative management, monitoring and anesthesia
management of anti-NMDAR encephalitis. This report was based on the consideration that controversial anesthetics
that likely act on NMDARs should be avoided. Additionally, BIS monitoring should to be prudently applied in
anti-NMDAR encephalitis because of abnormal electric encephalography (EEG). Anesthesiologists must be
careful with regard to central ventilation dysfunctions and PSH due to anti-NMDAR encephalitis.
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Background
Anti-N-methyl-D-aspartate receptor (NMDAR) enceph-
alitis is an immune-mediated syndrome characterised by
psychosis, seizures, sleep disorders, hallucinations and
short-term memory loss [1, 2]. This syndrome has been
predominantly described in young females (81 %), and
ovarian teratoma is the confirmed tumour associated
with anti-NMDAR antibodies [3]. One multi-centre
prospective epidemiological study demonstrated that
anti-NMDAR encephalitis accounted for 4 % of all en-
cephalitis cases [4]. Anti-NMDAR encephalitis has grad-
ually attracted the attention of anesthesiologists because
patients with anti-NMDAR encephalitis complicated by
ovarian teratoma require surgical treatment under general
anesthesia. Here, we describe two female patients who
presented for laparoscopic resection of the ovarian tera-
toma, they had confirmed anti-NMDAR encephalitis
accompanied by ovarian teratoma.
Case presentation
Case 1
A 31-year-old previously healthy woman (165 cm, 45 kg,
ASA I-II) was brought to the emergency room with con-
fusion, agitation, and auditory hallucinations after being
admitted to another hospital with seizures and agitation.
Intracranial infection was suspected; thus, sedation
and appropriate antibiotic treatment were started. The
following day, she suffered from hallucinations and
developed a regular, involuntary twitch in her right
upper limb, mouth, tongue and masticatory muscles.
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On admission, viral encephalitis was still suspected, a
sedative was given to prevent confusion and agitation, and
antiretroviral therapy was started with poor effect. Her
computed tomography (CT) and magnetic resonance im-
aging (MRI) results appeared normal. Cerebrospinal fluid
(CSF) and blood analyses showed no significant specific
abnormalities. Electroencephalography (EEG) revealed a
continuous 1–1.5 Hz sharp and slow mixed wave in
the front and central temporal area. On day 7 after
admission, other tests (Table 1) revealed anti-NMDAR
encephalitis associated with a left ovarian teratoma.
Anti-NMDAR encephalitis was diagnosed, and gamma
globulin (400 mg · kg−1 · d−1 for 5 days) treatment was
then started; a resection of the left ovarian teratoma under
general anaesthesia was scheduled.
The resection of the left ovarian teratoma was per-
formed under general anaesthesia on May 2, 2013. Pre-
anaesthetic medication was not administered. On arrival
to the operating room, the patient’s blood pressure was
105/60 mmHg, her heart rate was 75 beats · min−1 and her
pulse oxygen saturation was 99 % breathing room air.
General anaesthesia was induced with intravenous sufen-
tanil (15 μg), propofol (80 mg) and rocuronium (30 mg)
and was maintained with propofol (6 mg · kg−1 · h−1) and
remifentanil (0.1 μg · kg−1 · min−1). Muscle relaxation was
maintained with intermittent rocuronium. The patient’s
electrocardiography (ECG), non-invasive blood pressure,
and pulse oximetry were monitored. The patient’s intra-
operative systolic blood pressure was 100–120 mmHg,
and her heart rate was 60–80 beats · min−1. The case pro-
ceeded uneventfully. Muscle relaxations were reversed,
and the trachea was then extubated when the tidal volume
(TV) was 400 ml and the patient was able to open her
eyes in response to a moderate stimulus. Her physical
examination remained unchanged from that performed
pre-operatively, and no postoperative complications
were evident. The patient was transferred to the neuro-
intensive care unit. The durations of surgery and anaes-
thesia were 1 h: 05 min and 1 h: 45 min, respectively.
The total intraoperative blood loss was only 20 ml, the
urine output was 300 ml, and the total infusion volume
was 1000 ml. The tumour was solid, included hair and
cartilage, and was pathologically diagnosed as a mature
teratoma (Fig. 1a, b, c).
The patient’s condition gradually improved after surgery.
She received another gamma globulin (400 mg · kg−1 · d−1
for 5 days) treatment, and the course was uneventful.
The anti-NMDAR antibody levels in the blood and CSF
gradually decreased (Table 1), and the patient was dis-
charged on the 20th postoperative day.
Case 2
A 22-year-old woman (166 cm, 60 kg) was admitted to
another hospital with severe fever (39.0 °C) and headache
on May 18, 2014. An upper respiratory tract infection was
initially suspected, and an appropriate antibiotic treatment
was given for 7 days. Her fever was relieved after aspirin
but her recurrent fever and headache did not improve. In
Table 1 Tests for anti-NMDAR encephalitis associated with ovarian teratoma
Date Test Results
Case 1 Apr. 17, 2013 NMDAR antibodies Serum: positive (+)
CSF: Strong positive (++)
Apr. 18, 2013 Pelvic CT Left ovarian cystic lesions
Apr. 22, 2013 Pelvic Ultrasound Left ovarian cyst
May 9, 2013 NMDAR antibodies Serum: Weakly positive
CSF: positive (+)
May 14, 2013 Anatomopathology Ovarian mature cystic teratoma
May 22, 2013 NMDAR antibodies Serum: Negative (−)
CSF: Weakly positive
Case 2 June 16, 2014 NMDAR antibodies Serum: positive (+)
June 23, 2014 NMDAR antibodies Serum: Weakly positive
CSF: positive (+)
June 26, 2014 Pelvic Ultrasound Right ovarian cyst
June 26, 2014 Pelvic MRI Right ovarian cystic lesions
July 1, 2014 Anatomopathology Ovarian mature cystic teratoma
July 7, 2014 NMDAR antibodies Serum: Negative (−)
CSF: positive (+)
The NMDAR antibody results came from Peking Union Hospital; unfortunately, no precise values for NMDAR antibodies were obtained in the test reports. The
second patient rejected further testing for NMDAR antibodies after July 7, 2014
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the following days, she developed confusion, seizures and
a stiff neck. Consequently, she was transferred to our
hospital on June 5, 2014 for further evaluation.
On admission, viral encephalitis was suspected. Ap-
propriate antibiotics and sedation were given to treat
encephalitis and seizures, respectively. During the treat-
ment, nasal intubation was performed for excessive oral
secretions and pneumonia, and β-receptor blockers were
infused to alter sympathetic activity. Her cranial CT and
MRI results appeared normal, and the CSF analysis was
normal. A chest X-ray confirmed pneumonia, and blood
analysis demonstrated leucocytosis associated with
pneumonia. A targeted antibiotic was then used
against Staphylococcus aureus (sputum culture con-
firmed). A severely abnormal EEG displayed low ampli-
tude waves with slow rhythm in right occipital and
posterior temporal lobe and spike waves throughout the
brain (Fig. 2a). On day 11 after admission, other tests
(Table 1) revealed anti-NMDAR encephalitis associated
with right ovarian teratoma. Anti-NMDAR encephalitis
was diagnosed, and gamma globulin (400 mg · kg−1 · d−1
for 5 days) and methylprednisolone (40 mg Q12h) treat-
ment was then started. A resection of the right ovarian
teratoma under general anaesthesia was scheduled.
On June 26, 2014, the resection of the right ovarian
teratoma was performed under general anaesthesia.
Pre-anaesthetic medication was not administered. The
patient was transferred to the operating room with a
nasal endotracheal tube. Her blood pressure was 123/
88 mmHg, her heart rate was 127 beats · min−1, and
her body temperature was 38.8 °C. Multi-parameter
physiological monitoring showed an end-tidal carbon
dioxide (etCO2) value of 24 mmHg and a respiratory
rate (RR) of 32 beats · min−1, and arterial blood gas
analysis showed a pH of 7.55 and a PCO2 of 30 mmHg be-
fore induction. Esmolol was infused for sympathetic
hyperactivity. Mechanical ventilation (RR = 12, TV = 550)
started after induction with sufentanil (15 μg), propo-
fol (80 mg) and rocuronium (35 mg). General anaes-
thesia was maintained with propofol and remifentanil
Fig. 1 Figures of two cases from laparoscopic resection of ovarian teratoma to pathology. CASE 1: a Laparoscopic resection of the left ovarian
teratoma; b the left ovarian teratoma; c pathology of the left ovarian teratoma. CASE 2: d Laparoscopic resection of the right ovarian teratoma;
e the right ovarian teratoma; f pathology of the right ovarian teratoma
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(0.1 μg · kg−1 · min−1); the propofol infusion rate was
adjusted based on the bispectral index (BIS) (40–50).
The patient’s ECG, non-invasive blood pressure, pulse
oximetry, body temperature and BIS were monitored.
The patient’s intra-operative systolic blood pressure was
90–130 mmHg, her heart rate was 90–120 beats · min−1,
her body temperature was 38.5–38.8 °C and her BIS was
40–50. The case proceeded uneventfully. Muscle relax-
ation was reversed, and when the patient’s tidal volume
was greater than 400 ml and her pulse oxygen saturation
was more than 95 % with room air, she was transferred to
the neuro-intensive care unit with a nasal endotracheal
tube. The surgery and anaesthesia durations were 35 min
and 75 min, respectively. The intraoperative total blood
loss was only 10 ml, the urine output was 100 ml, and the
total infusion volume was 1000 ml. The tumour was solid,
included hair and cartilage, and was pathologically diag-
nosed as a mature teratoma (Fig. 1d, e, f ).
The patient was able to open her eyes and move her
upper limbs on command 1 day after surgery. She re-
ceived another gamma globulin (400 mg · kg−1 · d−1 for
5 days) treatment after surgery and showed further im-
provement. She recovered from pneumonia 26 days after
admission, and the nasal endotracheal tube was extu-
bated after her ability to swallow recovered. The patient
was discharged on the 46th postoperative day.
Discussion
The well-characterised NMDAR channel requires two
NR1 and two NR2 subunits to form a tetramer and is lo-
cated in the hippocampus, cerebral cortex, basal ganglia
and thalamus. NMDAR antibodies in encephalitis show
Fig. 2 Typical EEG of case 2 before resection of right ovarian teratoma. a Persistent high amplitude spikes (3.0–5.0 Hz) in all leads. b Generalised
rhythmic delta activity
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selectivity for NR1 subunits. Ectopic NMDAR expression
damages immune tolerance, eventually leading to anti-
NMDAR encephalitis. Hughes et al. [5] demonstrated that
in patients, NMDAR antibodies cause a selective and re-
versible decrease in NMDAR surface density and synaptic
localisation that correlates with patients’ antibody titres.
Anti-NMDAR encephalitis is often accompanied by tu-
mours, particularly teratomas because teratomas contain
both nervous tissue and the NMDA receptor subunit,
which acts as an antigen to induce antibody expression.
The antibodies in the serum and CSF combine with the
NMDAR in the basal forebrain, basal ganglia and cervical
spinal cord and cause the syndrome, which is charac-
terised by psychiatric disorders, short-term memory loss,
dyskinesias and autonomic instability [6].
Body temperature more than 38.3 °C occurs with an
incidence of up to 70 % in neuronal damage patients [7].
Many cases of fever of unknown origin have traditionally
been classified as central fever. Several studies suggest
that one of the key impacts of fever is an increase in
neuronal excitotoxicity [8], which also occurs in anti-
NMDAR encephalitis. NMDAR antibodies can block
NMDAR in the glutamatergic postsynaptic space and in
inhibitory GABAergic neurons. The experimental litera-
ture and clinical observations both confirmed the nega-
tive impact of fever in neuronal damage patients [9].
Antipyretic agents, including acetaminophen, aspirin, and
other nonsteroidal anti-inflammatory drugs, are believed
to lower the hypothalamic set point and activate the body’s
two principle mechanisms for heat dissipation: vasodilation
and sweating [10]. We can also use some nonpharmacolo-
gic interventions such as external cooling and intravascular
cooling to release the fever.
Anesthetics work by interacting with the ion channel
targets that regulate synaptic transmission and mem-
brane potentials in key brain and spinal cord regions.
The ion channel targets are differentially sensitive to
various anesthetic agents [11]. Anesthetics modify the
activation of the central nervous system by inhibiting
excitability neurons or exciting inhibitory neurons. Im-
portantly, NMDARs mediate excitatory neurotransmission
in the nervous system [12]. Various electrophysiological
studies have suggested that ketamine and nitrous oxide
minimally affect GABAA receptors but inhibit NMDARs
[13–15], so they should be avoided to such patients. Pro-
pofol was utilised to induce and maintain anesthesia for
the two patients in this report. The effect mechanism of
halogenated inhaled anesthetics and propofol is not very
clear still, no definitive conclusion has been drawn regard-
ing the contribution of NMDAR or GABAA receptors to
inhalation anesthetics and propofol. Pryzbylkowski et al.
[16] considered halogenated inhaled anesthetics to be
appropriate for anti-NMDAR encephalitis patients. Con-
versely, Hollman et al. [17] reported that the halogenated
ethers isoflurane, sevoflurane, and desflurane all inhibited
NMDAR to similar degrees at clinically equi-anesthetic
concentrations. Further research showed that sevoflurane,
isoflurane and xenon inhibited NMDA currents by 12, 31
and 39 %, respectively. It is different that the importance
and mechanism of NMDAR in pharmacology of haloge-
nated inhaled anesthetics, such as immobilization, senda-
tion and amnesia [18]. A large number of studies have
shown that propofol anesthetises by enhancing GABAer-
gic transmission [19, 20]. Although there are several re-
ports demonstrate that propofol also inhibits NMDAR in
clinically relevant concentrations [21, 22], GABAA recep-
tors play a major role in inducing anaesthesia [11]. Propo-
fol was utilised to induce and maintain anaesthesia for the
two patients in this report. Ideally, controversial anes-
thetics that likely act at NMDARs should be avoided.
NMDAR antagonists have been shown to augment
analgesia from opioids in acute and chronic settings and
to improve opioid-induced hyperalgesia (OIH) caused by
opioid exposure [16]. Moreover, the sustained increase
in the response of NMDARs via protein kinase-C-
mediated manganese removal seem to be the main
mechanisms implicated in OIH [23]. However, drawing
conclusions regarding whether anti-NMDAR encephal-
itis patients require more opioids or whether the OIH
incidence is decreasing and less NMDARs antagonists
are required is difficult, further investigations and re-
searches are expected.
EEG is useful in anti-NMDAR encephalitis, not only for
seizure and status epilepticus detection [24] but also for
diagnosis [25]. In a study addressing the EEG features of
23 anti-NMDAR encephalitis patients, the main findings
were diffuse background slowing with delta slow waves
and generalised extreme delta brush [26]. Generalised
rhythmic delta activity in anti-NMDAR encephalitis may
represent the effect of the antibodies against the NMDAR,
leading to reduced NMDA function [27]. Generalised
delta activity in case 2 was presented before resection of
right ovarian teratoma (Fig. 2b).
A report on anti-NMDAR encephalitis proposed
using the BIS to monitor such patients [28]. However,
as described above, many anti-NMDAR encephalitis
patients show abnormal EEGs, and the value of BIS
monitoring in these patients is controversial. The rec-
ommended propofol infusion rate is 4.5–9 mg/kg/h
combined with opioids [29]. However, a faster rate of
more than 10 mg/kg/h was used to maintain the optimal
BIS value (40–50) in the second case. An inherent pharma-
cokinetic and pharmacodynamic variability of propofol cer-
tainly exists among patients. Additionally, the therapeutic
propofol concentration is highly dependent on the surgical
stimulus. Nonetheless, the sensibility of using the BIS value
was suspect in the second case because of an abnormal
preoperative EEG.
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Paroxysmal sympathetic hyperactivity (PSH) is a syn-
drome of paroxysmal, episodic sympathetic hyperactivity
after acquired brain injury that has been recognised for
almost 60 years [30]. PSH accompanying anti-NMDAR
encephalitis may be associated with glutamate pathway
hyperactivity [31]. The patient in the second case pre-
sented some clinical manifestations of PSH, including
hypertonia and increased HR, RR, BP, temperature and
sweating. The first line medications for PSH include most
opioids, gabapentin, benzodiazepines, centrally acting α-
agonists, and β-antagonists [31]. Esmolol was given to
relieve PSH in the second case. Additionally, antihyperten-
sives and anticholinergics should also be used.
Central hypoventilation is a significant clinical feature of
anti-NMDAR encephalitis. However, similarly to a report
from Vural et al. [32], the patient in the second case
suffered from hyperventilation, which was possibly central
neurogenic hyperventilation. The inactivation of GABAer-
gic neurons due to an antibody-mediated decrease in
NMDA receptors may be involved in the complexity of
some abnormal movements via disinhibition of a brain-
stem central pattern generator [33], which is the possible
underline mechanism of central neurogenic hyperventila-
tion. Central ventilatory disorders should arouse the atten-
tion of anesthesiologists.
Conclusions
Currently, there is insufficient evidence about the peri-
operative management, monitoring and anesthesia man-
agement of anti-NMDAR encephalitis. This report was
based on the consideration that controversial anesthetics
that likely act on NMDARs should be avoided. Addition-
ally, BIS monitoring should to be prudently applied in
anti-NMDAR encephalitis. Anesthesiologists must be care-
ful with regard to central ventilatory disorders and PSH
due to anti-NMDAR encephalitis.
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